Lifestyle5 min read
Foundayo Sleep Apnea Results: Lilly's Pill Cuts Episodes 44%
Foundayo sleep apnea trial results: Lilly's GLP-1 pill cut breathing interruptions up to 44% in a year-long study. FDA filing timing and how it compares.
What America is talking about today
Topic
Foundayo sleep apnea trial results: Lilly's GLP-1 pill cut breathing interruptions up to 44% in a year-long study. FDA filing timing and how it compares.
Eli Lilly's Q3 2026 earnings beat estimates on $24.4 billion in revenue, and Lilly raised its 2026 sales outlook to $91-92 billion. What moved LLY stock.